Stockscreener 앱 받기
0.5262
2.56%
-0.0138
시간 외 거래:
.53
0.0038
+0.72%
전일 마감가:
$0.54
열려 있는:
$0.54
하루 거래량:
215.86K
Relative Volume:
0.43
시가총액:
$28.10M
수익:
-
순이익/손실:
$-151.16M
주가수익비율:
-0.1772
EPS:
-2.97
순현금흐름:
$-130.08M
1주 성능:
+3.87%
1개월 성능:
+14.97%
6개월 성능:
-65.27%
1년 성능:
-91.37%
1일 변동 폭
$0.5081
$0.54
1주일 범위
$0.444
$0.54
52주 변동 폭
$0.404
$6.3786
AIx 온콜로지 Stock (ALXO) Company Profile
명칭
Alx Oncology Holdings Inc
전화
650-466-7125
주소
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
ALXO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALXO
Alx Oncology Holdings Inc
|
0.5262 | 28.86M | 0 | -151.16M | -130.08M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
AIx 온콜로지 Stock (ALXO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-12-19 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-03-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-12-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-09-30 | 개시 | Stifel | Buy |
| 2021-05-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-04-06 | 개시 | UBS | Buy |
| 2021-02-10 | 개시 | H.C. Wainwright | Buy |
| 2020-08-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-08-11 | 개시 | Credit Suisse | Outperform |
| 2020-08-11 | 개시 | Jefferies | Buy |
| 2020-08-11 | 개시 | Piper Sandler | Overweight |
모두보기
AIx 온콜로지 주식(ALXO)의 최신 뉴스
Why did ALXO's EPS remain flat throughout 2024? - AInvest
Why ALX Oncology Holdings Inc. stock attracts strong analyst attentionStable Growth Stock Picks - Newser
Alx Oncology Faces Delisting Threat: Nasdaq Compliance Deadline Looms - TipRanks
How ALX Oncology Holdings Inc. stock performs during market volatilityVerified Chart Patterns - Newser
What analysts say about ALX Oncology Holdings Inc. stockTriple returns potential - Autocar Professional
ALX Oncology Holdings Inc. Stock Analysis and ForecastPhenomenal returns - Autocar Professional
Is ALX Oncology Holdings Inc. stock overhyped or has real potentialAccelerated financial growth - jammulinksnews.com
What drives ALX Oncology Holdings Inc. stock priceOverwhelming profit margins - jammulinksnews.com
Is ALX Oncology Holdings Inc. a good long term investmentMarket-beating returns - jammulinksnews.com
Will ALX Oncology Holdings Inc. stock benefit from interest rate changesConsistent Win Signals - Newser
What makes ALX Oncology Holdings Inc. stock price move sharplyRisk Adjusted Stock Signals - Newser
ALX Oncology (NASDAQ:ALXO) Trading Down 3.5% – What’s Next? - Defense World
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of “Moderate Buy” by Analysts - Defense World
ALX Oncology Confirms Directors at Annual Meeting - TipRanks
ALX Oncology reports annual meeting results By Investing.com - Investing.com Nigeria
ALX Oncology reports annual meeting results - Investing.com
Cantor Fitzgerald Weighs in on ALX Oncology FY2026 Earnings - Defense World
ALX Oncology (NASDAQ:ALXO) Downgraded to “Sell” Rating by Wall Street Zen - Defense World
Nuveen Asset Management LLC Has $275,000 Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares Acquired by Two Sigma Investments LP - Defense World
Bank of America Corp DE Grows Position in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares Acquired by Deutsche Bank AG - Defense World
Northern Trust Corp Acquires 23,324 Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference - GlobeNewswire
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference | ALXO Stock News - GuruFocus
ALX Oncology Management to Showcase Novel Cancer Treatment Advances at Major Jefferies Healthcare Conference - Stock Titan
D. E. Shaw & Co. Inc. Decreases Stock Position in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
H.C. Wainwright maintains ALX Oncology stock Buy rating By Investing.com - Investing.com India
H.C. Wainwright maintains ALX Oncology stock Buy rating - Investing.com
AIx 온콜로지 (ALXO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.97%
0.22%
자본화:
|
볼륨(24시간):